Brook, M., Hennessy, C., Hester, J., Hammad, S., Alzhrani, A., Rombach, I., . . . Issa, F. (2024). Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation. Wolters Kluwer.
Citação norma ChicagoBrook, MO, et al. Late Treatment with Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation. Wolters Kluwer, 2024.
Citação norma MLABrook, MO, et al. Late Treatment with Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation. Wolters Kluwer, 2024.